The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A first-in-human phase 1 study of proxalutamide (GT0918), a dual MOA androgen receptor blocker in patients with advanced CRPC.
 
Tie Zhou
No Relationships to Disclose
 
Wei-Dong Xu
No Relationships to Disclose
 
Chuang-Liang Xu
No Relationships to Disclose
 
Xu Gao
Employment - Changhai Hospital
 
Jian-Guo Hou
No Relationships to Disclose
 
Shancheng Ren
Employment - Changhai Hospital
 
Bo Yang
Employment - Changhai Hospital
 
Guolan Wei
Employment - Covance
 
Ye Sun
Employment - Suzhou Kintor Pharmaceuticals
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals
 
Chunyun Chen
Employment - Suzhou Kintor Pharmaceuticals
Leadership - Suzhou Kintor Pharmaceuticals
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals
 
Chuangxing Guo
Employment - Suzhou Kintor Pharmaceuticals
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals
 
Youzhi Tong
Employment - Suzhou Kintor Pharmaceuticals
Leadership - Suzhou Kintor Pharmaceuticals
Stock and Other Ownership Interests - Suzhou Kintor Pharmaceuticals
 
Karl Zhou
Consulting or Advisory Role - Suzhou Kintor Pharmaceuticals
 
Ying-Hao Sun
Consulting or Advisory Role - Suzhou Kintor Pharmaceuticals